Evidence map›Paper›PMID 27382373›Full record

ArticleJournal of environmental and public health2016

Arsenic in Drinking Water and Lung Cancer Mortality in the United States: An Analysis Based on US Counties and 30 Years of Observation (1950-1979).

Hamid Ferdosi, Elisabeth K Dissen, Nana Ama Afari-Dwamena, Ji Li, Rusan Chen, Manning Feinleib, Steven H Lamm

Open access · hybridAbstract read
In one paragraph

Article in Journal of environmental and public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  3. Review
  4. Curcumin prevents AsChinese medicine · 2021
    Article
  5. Paradoxical effects of arsenic in the lungs.Environmental health and preventive medicine · 2021
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hamid FerdosiCenter for Epidemiology and Environmental Health, CEOH, LLC, 3401 38th Street NW, Suite 615, Washington, DC 20016, USA; Milken Institute School of Public Health, George Washington University, 950 New Hampshire Avenue NW, Washington, DC 20052, USA.ORCID 0000-0003-2941-2394
Elisabeth K DissenCenter for Epidemiology and Environmental Health, CEOH, LLC, 3401 38th Street NW, Suite 615, Washington, DC 20016, USA.ORCID 0000-0001-7969-5316
Nana Ama Afari-DwamenaCenter for Epidemiology and Environmental Health, CEOH, LLC, 3401 38th Street NW, Suite 615, Washington, DC 20016, USA.
Ji LiCenter for Epidemiology and Environmental Health, CEOH, LLC, 3401 38th Street NW, Suite 615, Washington, DC 20016, USA; Department of Pathology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Rusan ChenCenter for New Designs in Learning and Scholarship, Georgetown University, 3520 Prospect Street NW, No. 314, Washington, DC 20057, USA.
Manning FeinleibJohns Hopkins University Bloomberg School of Public Health, 615 N Wolfe Street, No. 5041, Baltimore, MD 21205, USA.
Steven H LammCenter for Epidemiology and Environmental Health, CEOH, LLC, 3401 38th Street NW, Suite 615, Washington, DC 20016, USA; Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe Street, No. 5041, Baltimore, MD 21205, USA; Georgetown University School of Medicine, 3800 Reservoir Road NW, Washington, DC 20007, USA.
Johns Hopkins University · USCenter for Environmental Health · USGeorgetown University · USMilken Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. To examine whether the US EPA (2010) lung cancer risk estimate derived from the high arsenic exposures (10-934 µg/L) in southwest Taiwan accurately predicts the US experience from low arsenic exposures (3-59 µg/L). Methods. Analyses have been limited to US counties solely dependent on underground sources for their drinking water supply with median arsenic levels of ≥3 µg/L. Results. Cancer risks (slopes) were found to be indistinguishable from zero for males and females. The addition of arsenic level did not significantly increase the explanatory power of the models. Stratified, or categorical, analysis yielded relative risks that hover about 1.00. The unit risk estimates were nonpositive and not significantly different from zero, and the maximum (95% UCL) unit risk estimates for lung cancer were lower than those in US EPA (2010). Conclusions. These data do not demonstrate an increased risk of lung cancer associated with median drinking water arsenic levels in the range of 3-59 µg/L. The upper-bound estimates of the risks are lower than the risks predicted from the SW Taiwan data and do not support those predictions. These results are consistent with a recent metaregression that indicated no increased lung cancer risk for arsenic exposures below 100-150 µg/L.

Indexed as

ArsenicDrinking WaterFemaleHumansLung NeoplasmsMaleRisk FactorsTaiwanUnited StatesUnited States Environmental Protection AgencyWater Pollutants, ChemicalArsenicDrinking WaterWater Pollutants, Chemical

Identifiers

PMID27382373
PMCPMC4921645
OpenAlexW2430954239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.